Numerous studies indicate that CAF lowers the ability of CD8+ T lymphocytes to kill tumor cells by reducing T cell penetration into the tumor, preventing T cell trafficking in the microenvironment, and lowering cytotoxic activity (Freeman and Mielgo, 2020). Here, CD8A is linked to neoplasm.